Ahmed, Fozia Z.
University of Copenhagen · Mayo Clinic · University of Leicester · University of Manchester · NIHR Leicester Biomedical Research Centre · University of Missouri–Kansas City · University of Glasgow
4 papers on CoChatORCID 0000-0001-9769-0180
Most cited papers
- Verified
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G. K., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., et al. (2023) · New England Journal of Medicine
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 1,669
- Verified
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Kosiborod, M. N., Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Hovingh, G. K., Kitzman, D. W., Møller, D. V., Treppendahl, M. B., Verma, S., et al. (2024) · New England Journal of Medicine
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 758
- Verified
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Butler, J., Shah, S. J., Petrie, M. C., Borlaug, B. A., Abildstrøm, S. Z., Davies, M. J., Hovingh, G. K., Kitzman, D. W., Møller, D. V., Verma, S., et al. (2024) · The Lancet
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 386
- Verified
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Borlaug, B. A., Kitzman, D. W., Davies, M. J., Rasmussen, S., Barros, E., Butler, J., Einfeldt, M. N., Hovingh, G. K., Møller, D. V., Petrie, M. C., et al. (2023) · Nature Medicine
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 215
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free